Disclosure Quest - Search SEC Filings

Name	Type of Offering	Accepted Date
Indaptus Therapeutics, Inc. See All Filings	D	2025-06-20 16:05:31 UTC
Amount To Be Raised $5,000,000 Associated Brokers / Dealers Paulson Investment Company, LLC CIK Number 0001857044 Filed Document 0001641172-25-015841 Exclusions or Exemptions 506c Accepted Date 2025-06-20 16:05:31 UTC Type of Offering D Industry Pharmaceuticals Principal Place of Business NEW YORK Revenue or Assets Decline to Disclose Type of Security Option To Acquire
Indaptus Therapeutics, Inc. See All Filings	D	2025-01-22 17:01:18 UTC
Amount To Be Raised $2,246,500 Associated Brokers / Dealers Paulson Investment Company, LLC CIK Number 0001857044 Filed Document 0001493152-25-003248 Exclusions or Exemptions 506b Accepted Date 2025-01-22 17:01:18 UTC Type of Offering D Industry Pharmaceuticals Principal Place of Business NEW YORK Revenue or Assets Decline to Disclose Type of Security Equity
Indaptus Therapeutics, Inc. See All Filings	D	2024-12-06 16:36:22 UTC
Amount To Be Raised $227,127 Associated Brokers / Dealers Paulson Investment Company, LLC CIK Number 0001857044 Filed Document 0001857044-24-000003 Exclusions or Exemptions 506b Accepted Date 2024-12-06 16:36:22 UTC Type of Offering D Industry Pharmaceuticals Principal Place of Business NEW YORK Revenue or Assets Decline to Disclose Type of Security Option To Acquire
Indaptus Therapeutics, Inc. See All Filings	D/A	2024-10-04 17:21:50 UTC
Amount To Be Raised $205,480 Associated Brokers / Dealers Paulson Investment Company, LLC CIK Number 0001857044 Filed Document 0001857044-24-000002 Exclusions or Exemptions 506b Accepted Date 2024-10-04 17:21:50 UTC Type of Offering D/A Industry Pharmaceuticals Principal Place of Business NEW YORK Revenue or Assets Decline to Disclose Type of Security Option To Acquire
Indaptus Therapeutics, Inc. See All Filings	D	2024-08-22 10:06:25 UTC
Amount To Be Raised $205,480 Associated Brokers / Dealers Paulson Investment Company, LLC CIK Number 0001857044 Filed Document 0001857044-24-000001 Exclusions or Exemptions 506b Accepted Date 2024-08-22 10:06:25 UTC Type of Offering D Industry Pharmaceuticals Principal Place of Business NEW YORK Revenue or Assets Decline to Disclose Type of Security Option To Acquire